Archive


Category: Artifical Intellgence

  • Smartphone-based skin cancer diagnostic certified for use in UK

    An artificial intelligence-powered digital tool for diagnosing skin cancers developed by Skin Analytics has been cleared in the UK as a Class IIA medical device, setting up broader use of the technology in patient assessments. DERM is being deployed in pilot studies across five NHS Trusts, for example to see if it can support GPs […]

  • Another big AI deal as Sanofi taps Exscientia for 15 new drugs

    If the last couple of days is an indication, 2022 is already shaping up to be the year of big-ticket alliances between big pharma companies and specialists in artificial intelligence-driven discovery. Shortly after Amgen unveiled its $1.9 billion alliance with Generate Biomedicines aimed initially at five drug molecules, Sanofi has announced a big expansion of […]

  • AI tool may help doctors select best drugs for COVID patients

    Researchers in the US have developed an artificial intelligence-based tool that is able to predict COVID-19 symptoms and suggest which FDA-approved drugs might be used to treat patients. The MOATAI-VIR algorithm, developed by scientists at Emory University and Georgia Tech, was put through its paces in a study that showed it was able to predict […]

  • UK adults asked to record coughs to improve COVID detection

    Researchers in the UK are asking adults who have taken a COVID-19 test in the last 72 hours to record themselves coughing, breathing and speaking to help develop new ways to detect infection. The aim is to develop algorithms that could be used to detect COVID-19 remotely – for example before a PCR or lateral […]

  • AI drug discovery biotech AbCellera eyes record IPO

    AbCellera Biologics has been in the spotlight since coming up with Eli Lilly’s COVID-19 antibody drug bamlanivimab, and looks set to capitalise on that exposure with a sizeable initial public offering. The Vancouver, Canada-headquartered biotech – which has been bankrolled in part by billionaire entrepreneur and venture capitalist Peter Thiel – plans to offer 23 […]

  • BioNTech, InstaDeep plan joint lab for AI research

    BioNTech may be deeply ensconced in the latter stages of its bid to bring a COVID-19 vaccine to market, but it’s still pushing forward on other fronts, including a partnership with InstaDeep to deploy artificial intelligence and machine learning across its business. The two companies have been working together in this area since 2019, but […]

  • AI-ML Drug Discovery & Development Summit 2021

    Visit our website: www.ai-drugdiscovery.com R&D & Clinical Processes for the Future: Accurate, Efficient & Cost-Effective The AI-ML: Drug Discovery and Development Summit is the industry’s definitive guide to translating the wealth of tech available to successfully implement a working and practically effective drug discovery and development platform. Designed with leading AI experts from R&D and […]